US biotech seems reenergized, but unsettled policy questions take a back seat to pending national elections, particularly with the presidency at stake. Jeffrey L Fox reports.
This is a preview of subscription content, access via your institution
Access options
References
Fox, J.L. Nat. Biotechnol. 29, 303–305 (2011).
Anonymous. Nat. Biotechnol. 30, 198 (2012).
Fox, J.L. Nat. Biotechnol. 29, 953–954 (2011).
Fox, J.L. Nat. Biotechnol. 29, 1062 (2011).
Mullard, A. Nat. Rev. Drug Discov. 11, 91–94 (2012).
Fox, J.L. Nat. Biotechnol. 28, 1141–1142 (2010).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fox, J. Positive signals from Washington. Nat Biotechnol 30, 306–308 (2012). https://doi.org/10.1038/nbt.2175
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2175